BA9 Transcriptomics in Huntington's Disease 80-Gene Signature and MIR219A2-Linked Targets

Area of Science:

• Neuroscience
• Genetics
• Bioinformatics

Background:

• Huntington's disease (HD) is characterized by widespread cortical transcriptional dysregulation.
• Prefrontal Brodmann Area 9 (BA9) is significantly affected in HD, making it a key region for investigation.

Purpose of the Study:

• To re-examine prefrontal BA9 RNA-seq data from HD patients and controls.
• To identify differentially expressed genes and pathways associated with HD in BA9.
• To investigate the role of MIR219A2 and its targets in HD-related transcriptional changes.

Main Methods:

• Utilized BH-FDR and GEO2R for differential gene expression analysis of BA9 RNA-seq data.
• Performed in silico integration of validated target sets and full-universe testing.
• Applied miRTarBase and ENCORI/starBase CLIP data to assess MIR219A2 target enrichment.
• Analyzed transcription factor (TF) target set over-representation using MSigDB C3:TFT and TRRUST v2.

Main Results:

• Identified 2923 up-regulated and 2448 down-regulated genes in BA9 at FDR < 0.05, with a mild predominance of up-regulation.
• Found strong down-regulation of MIR219A2 and significant, direction-consistent enrichment of its targets in the up-regulated gene universe.
• Revealed significant over-representation of TF target sets (e.g., NFAT, C/EBP, FOXA/HNF3) among BA9 up-regulated genes.

Conclusions:

• The findings support a BA9-specific, MIR219A2-aligned association signal in Huntington's disease.
• Transcriptional dysregulation in BA9 involves down-regulation of MIR219A2 and altered TF activity.
• These results provide a foundation for further hypothesis-generating research into HD mechanisms.